These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24983404)
1. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. Cai Z; Ouyang Q; Zeng D; Nguyen KN; Modi J; Wang L; White AG; Rogers BE; Xie XQ; Anderson CJ J Med Chem; 2014 Jul; 57(14):6019-29. PubMed ID: 24983404 [TBL] [Abstract][Full Text] [Related]
2. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Nedrow JR; White AG; Modi J; Nguyen K; Chang AJ; Anderson CJ Mol Imaging; 2014; 13():. PubMed ID: 25060207 [TBL] [Abstract][Full Text] [Related]
4. Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides. Cai Z; Li BT; Wong EH; Weisman GR; Anderson CJ Dalton Trans; 2015 Mar; 44(9):3945-8. PubMed ID: 25645688 [TBL] [Abstract][Full Text] [Related]
5. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Guo Y; Ferdani R; Anderson CJ Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248 [TBL] [Abstract][Full Text] [Related]
6. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Zeng D; Guo Y; White AG; Cai Z; Modi J; Ferdani R; Anderson CJ Mol Pharm; 2014 Nov; 11(11):3980-7. PubMed ID: 24720806 [TBL] [Abstract][Full Text] [Related]
7. Ocak M; Beaino W; White A; Zeng D; Cai Z; Anderson CJ Cancer Biother Radiopharm; 2018 Mar; 33(2):74-83. PubMed ID: 29634417 [TBL] [Abstract][Full Text] [Related]
8. Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. Lewis JS; Lewis MR; Srinivasan A; Schmidt MA; Wang J; Anderson CJ J Med Chem; 1999 Apr; 42(8):1341-7. PubMed ID: 10212119 [TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors. Wadas TJ; Eiblmaier M; Zheleznyak A; Sherman CD; Ferdani R; Liang K; Achilefu S; Anderson CJ J Nucl Med; 2008 Nov; 49(11):1819-27. PubMed ID: 18927338 [TBL] [Abstract][Full Text] [Related]
10. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates. Beaino W; Anderson CJ J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake. Lewis JS; Srinivasan A; Schmidt MA; Anderson CJ Nucl Med Biol; 1999 Apr; 26(3):267-73. PubMed ID: 10363797 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model. Petersen AL; Binderup T; Jølck RI; Rasmussen P; Henriksen JR; Pfeifer AK; Kjær A; Andresen TL J Control Release; 2012 Jun; 160(2):254-63. PubMed ID: 22245688 [TBL] [Abstract][Full Text] [Related]
13. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. Cai Z; Anderson CJ J Labelled Comp Radiopharm; 2014 Apr; 57(4):224-30. PubMed ID: 24347474 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers. Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Evaluation of Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911 [TBL] [Abstract][Full Text] [Related]
16. New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides. Zeng D; Ouyang Q; Cai Z; Xie XQ; Anderson CJ Chem Commun (Camb); 2014 Jan; 50(1):43-5. PubMed ID: 24141371 [TBL] [Abstract][Full Text] [Related]
17. Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method. Yim CB; van der Wildt B; Dijkgraaf I; Joosten L; Eek A; Versluis C; Rijkers DT; Boerman OC; Liskamp RM Chembiochem; 2011 Mar; 12(5):750-60. PubMed ID: 21328514 [TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation. Zhou Z; Chitneni SK; Devoogdt N; Zalutsky MR; Vaidyanathan G Bioorg Med Chem; 2018 May; 26(8):1939-1949. PubMed ID: 29534937 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of Re/ Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453 [TBL] [Abstract][Full Text] [Related]
20. PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Paterson BM; Roselt P; Denoyer D; Cullinane C; Binns D; Noonan W; Jeffery CM; Price RI; White JM; Hicks RJ; Donnelly PS Dalton Trans; 2014 Jan; 43(3):1386-96. PubMed ID: 24202174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]